Body wash "meaningful" clinical use questioned by FDAers at HCCM symposium.
This article was originally published in The Tan Sheet
Executive Summary
ANTIMICROBIAL BODY WASH CLINICAL USEFULNESS QUESTIONED by David Bostwick, a clinical reviewer in the FDA's Division of Anti-infective Drug Products, at a June 2-3 symposium on the Healthcare Continuum Model held jointly by the Cosmetic, Toiletry & Fragrance Association and the Soap & Detergent Association in Washington, D.C. The model, proposed to FDA in 1995, is the industry's suggested regulatory scheme for antimicrobial ingredient-containing wash products used by consumers, food handlers and healthcare professionals ("The Tan Sheet" April 3, 1995, p. 15). The proposal, released in March 1995, responded to FDA's 1994 TFM that would set up a scheme for agency oversight of antimicrobial skin cleaners ("The Tan Sheet" June 27, 1994, pp. 7-10).